Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Berger

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Oncogene|November 3, 2015
mTORC1 directly phosphorylates and activates ERα upon estrogen stimulationA Alayev, R S Salamon, S M Berger, et al.
Clinical Obesity|April 16, 2015
Impact of metabolic disorders on the relation between overweight/obesity and incident myocardial infarction and ischaemic stroke in fertile women: a nationwide cohort studyS S Andersen, C Andersson, S M Berger, et al.
Clinical Lung Cancer|March 28, 2026
Durable Response to Sequential ROS1-TKIs in Metastatic Squamous NSCLC With EZR-ROS1 Fusion: A Case ReportAnne-Mette A Konradsen, Eva S Petersson, Morten Grauslund, et al.
Immuno-Oncology Technology|January 1, 2026
Ligand-receptor interactions of V-domain Ig-containing suppressor of T cell activation and programmed death-1 suppress the anticancer activities of T cellsM Abooali, X Lei, I M Yasinska, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Oncogene|November 3, 2015
mTORC1 directly phosphorylates and activates ERα upon estrogen stimulationA Alayev, R S Salamon, S M Berger, et al.
Clinical Obesity|April 16, 2015
Impact of metabolic disorders on the relation between overweight/obesity and incident myocardial infarction and ischaemic stroke in fertile women: a nationwide cohort studyS S Andersen, C Andersson, S M Berger, et al.
Clinical Lung Cancer|March 28, 2026
Durable Response to Sequential ROS1-TKIs in Metastatic Squamous NSCLC With EZR-ROS1 Fusion: A Case ReportAnne-Mette A Konradsen, Eva S Petersson, Morten Grauslund, et al.
Immuno-Oncology Technology|January 1, 2026
Ligand-receptor interactions of V-domain Ig-containing suppressor of T cell activation and programmed death-1 suppress the anticancer activities of T cellsM Abooali, X Lei, I M Yasinska, et al.
Pageof 2